De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
HealthEquity Inkomsten in het verleden
Verleden criteriumcontroles 5/6
HealthEquity is de winst gegroeid met een gemiddeld jaarlijks percentage van 5.3%, terwijl de Healthcare industrie de winst jaarlijks groeide met 6.2%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 15.2% per jaar. Het rendement op eigen vermogen van HealthEquity is 4.9%, en het heeft een nettomarge van 9.6%.
Belangrijke informatie
5.3%
Groei van de winst
-2.6%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 8.5% |
| Inkomstengroei | 15.2% |
| Rendement op eigen vermogen | 4.9% |
| Nettomarge | 9.6% |
| Laatste winstupdate | 31 Jul 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Getting In Cheap On HealthEquity, Inc. (NASDAQ:HQY) Might Be Difficult
Aug 30
HealthEquity: Compelling Catalysts, Fairly Valued, Reiterate Buy
Aug 27Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?
Jul 13We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation
Jun 21Earnings Beat: HealthEquity, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jun 07HealthEquity: A Trading Vehicle Performing As Expected, Strong Growth Hard To Ignore
Jun 04HealthEquity: Strong Growth And Healthy Cash Flows Changed My Mind
May 29Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?
May 03Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues
Apr 11HealthEquity: Multiple Compression Has Finally Made It A Buy
Mar 21Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects
Dec 28Is HealthEquity (NASDAQ:HQY) A Risky Investment?
Nov 17HealthEquity, Inc.'s (NASDAQ:HQY) Intrinsic Value Is Potentially 51% Above Its Share Price
Oct 26Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?
Jul 27HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jul 07Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?
Apr 18Estimating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)
Mar 14Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?
Dec 24Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Dec 02Is HealthEquity, Inc. (NASDAQ:HQY) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 11These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively
Sep 08HealthEquity Non-GAAP EPS of $0.33 in-line, revenue of $206.1M beats by $2.22M
Sep 06HealthEquity: Asymmetry In Valuation Continues To Widen
Aug 25HealthEquity COO steps down, CEO to assume his responsibilities
Aug 02Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Jul 27Calculating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)
Jul 06These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively
May 24Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Apr 12An Intrinsic Calculation For HealthEquity, Inc. (NASDAQ:HQY) Suggests It's 29% Undervalued
Mar 16Opbrengsten en kosten
Hoe HealthEquity geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Jul 24 | 1,099 | 106 | 206 | 226 |
| 30 Apr 24 | 1,043 | 80 | 199 | 222 |
| 31 Jan 24 | 1,000 | 56 | 183 | 219 |
| 31 Oct 23 | 971 | 29 | 180 | 216 |
| 31 Jul 23 | 938 | 13 | 177 | 210 |
| 30 Apr 23 | 901 | -8 | 172 | 201 |
| 31 Jan 23 | 862 | -26 | 166 | 193 |
| 31 Oct 22 | 831 | -59 | 162 | 187 |
| 31 Jul 22 | 795 | -62 | 152 | 176 |
| 30 Apr 22 | 778 | -55 | 148 | 167 |
| 31 Jan 22 | 757 | -44 | 144 | 157 |
| 31 Oct 21 | 741 | -6 | 142 | 144 |
| 31 Jul 21 | 741 | 1 | 144 | 136 |
| 30 Apr 21 | 728 | 4 | 139 | 129 |
| 31 Jan 21 | 734 | 9 | 134 | 125 |
| 31 Oct 20 | 747 | 3 | 122 | 124 |
| 31 Jul 20 | 724 | -20 | 132 | 117 |
| 30 Apr 20 | 635 | 0 | 117 | 98 |
| 31 Jan 20 | 532 | 40 | 105 | 78 |
| 31 Oct 19 | 407 | 53 | 97 | 56 |
| 31 Jul 19 | 320 | 90 | 68 | 41 |
| 30 Apr 19 | 304 | 93 | 66 | 38 |
| 31 Jan 19 | 287 | 74 | 63 | 35 |
| 31 Oct 18 | 272 | 67 | 60 | 33 |
| 31 Jul 18 | 258 | 61 | 56 | 31 |
| 30 Apr 18 | 244 | 56 | 52 | 29 |
| 31 Jan 18 | 230 | 47 | 48 | 27 |
| 31 Oct 17 | 216 | 46 | 44 | 26 |
| 31 Jul 17 | 202 | 41 | 42 | 26 |
| 30 Apr 17 | 190 | 32 | 40 | 24 |
| 31 Jan 17 | 178 | 26 | 38 | 22 |
| 31 Oct 16 | 167 | 25 | 36 | 21 |
| 31 Jul 16 | 155 | 24 | 33 | 19 |
| 30 Apr 16 | 141 | 20 | 30 | 18 |
| 31 Jan 16 | 127 | 17 | 27 | 17 |
| 31 Oct 15 | 116 | 15 | 26 | 15 |
| 31 Jul 15 | 107 | 14 | 24 | 14 |
| 30 Apr 15 | 97 | 13 | 22 | 12 |
| 31 Jan 15 | 88 | 12 | 19 | 11 |
| 31 Oct 14 | 80 | 1 | 16 | 9 |
| 31 Jul 14 | 74 | -1 | 15 | 8 |
| 30 Apr 14 | 68 | -4 | 13 | 8 |
| 31 Jan 14 | 62 | -7 | 12 | 7 |
Kwaliteitswinsten: HQY heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (9.6%) HQY } zijn hoger dan vorig jaar (1.4%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van HQY is de afgelopen 5 jaar met 5.3% per jaar gegroeid.
Versnelling van de groei: De winstgroei van HQY over het afgelopen jaar ( 724% ) overtreft het 5-jarig gemiddelde ( 5.3% per jaar).
Winst versus industrie: De winstgroei HQY over het afgelopen jaar ( 724% ) overtrof de Healthcare -sector 8%.
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 4.9% ) van HQY wordt als laag beschouwd.